Khorana AA - Search Results

1

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.

Khorana AA, Rosenblatt JD, Sahasrabudhe DM, Evans T, Ladrigan M, Marquis D, Rosell K, Whiteside T, Phillippe S, Acres B, Slos P, Squiban P, Ross M, Kendra K. Khorana AA, et al. Cancer Gene Ther. 2003 Apr;10(4):251-9. doi: 10.1038/sj.cgt.7700568. Cancer Gene Ther. 2003. PMID: 12679797 Clinical Trial.

2

Immunopathogenesis of HIV and HTLV-1 infection: mechanisms for lymphomagenesis.

Khorana AA, Rosenblatt JD, Young FM. Khorana AA, et al. Cancer Treat Res. 2001;104:19-74. doi: 10.1007/978-1-4615-1601-9_2. Cancer Treat Res. 2001. PMID: 11191127 Review. No abstract available.

3

Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis.

Khorana AA, Ryan CK, Cox C, Eberly S, Sahasrabudhe DM. Khorana AA, et al. Cancer. 2003 Feb 15;97(4):960-8. doi: 10.1002/cncr.11152. Cancer. 2003. PMID: 12569594 Free article.

4

The influence of host response on colorectal cancer prognosis.

Shunyakov L, Ryan CK, Sahasrabudhe DM, Khorana AA. Shunyakov L, et al. Among authors: khorana aa. Clin Colorectal Cancer. 2004 May;4(1):38-45. doi: 10.3816/ccc.2004.n.008. Clin Colorectal Cancer. 2004. PMID: 15207019 Review.

5

A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.

Kuderer NM, Khorana AA, Lyman GH, Francis CW. Kuderer NM, et al. Among authors: khorana aa. Cancer. 2007 Sep 1;110(5):1149-61. doi: 10.1002/cncr.22892. Cancer. 2007. PMID: 17634948 Free article. Review.

6

Cancer patients and awareness of venous thromboembolism.

Sousou T, Khorana AA. Sousou T, et al. Among authors: khorana aa. Cancer Invest. 2010 Jan;28(1):44-5. doi: 10.3109/07357900902744544. Cancer Invest. 2010. PMID: 20001296

7

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.

Khorana AA, Francis CW, Culakova E, Lyman GH. Khorana AA, et al. Cancer. 2005 Dec 15;104(12):2822-9. doi: 10.1002/cncr.21496. Cancer. 2005. PMID: 16284987 Free article.

8

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Khorana AA, et al. Cancer. 2007 Nov 15;110(10):2339-46. doi: 10.1002/cncr.23062. Cancer. 2007. PMID: 17918266 Free article.

9

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.

Khorana AA, Dalal M, Lin J, Connolly GC. Khorana AA, et al. Cancer. 2013 Feb 1;119(3):648-55. doi: 10.1002/cncr.27772. Epub 2012 Aug 14. Cancer. 2013. PMID: 22893596 Free article.

10

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer.

Hezel AF, Noel MS, Allen JN, Abrams TA, Yurgelun M, Faris JE, Goyal L, Clark JW, Blaszkowsky LS, Murphy JE, Zheng H, Khorana AA, Connolly GC, Hyrien O, Baran A, Herr M, Ng K, Sheehan S, Harris DJ, Regan E, Borger DR, Iafrate AJ, Fuchs C, Ryan DP, Zhu AX. Hezel AF, et al. Among authors: khorana aa. Br J Cancer. 2014 Jul 29;111(3):430-6. doi: 10.1038/bjc.2014.343. Epub 2014 Jun 24. Br J Cancer. 2014. PMID: 24960403 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page